Reaction Details |
| Report a problem with these data |
Target | Kallikrein-8 |
---|
Ligand | BDBM50525901 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1898430 (CHEMBL4400465) |
---|
IC50 | 12589±n/a nM |
---|
Citation | Walker, AL; Denis, A; Bingham, RP; Bouillot, A; Edgar, EV; Ferrie, A; Holmes, DS; Laroze, A; Liddle, J; Fouchet, MH; Moquette, A; Nassau, P; Pearce, AC; Polyakova, O; Smith, KJ; Thomas, P; Thorpe, JH; Trottet, L; Wang, Y; Hovnanian, A Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors. Bioorg Med Chem Lett29:0 (2019) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Kallikrein-8 |
---|
Name: | Kallikrein-8 |
Synonyms: | KLK8 | KLK8_HUMAN | Kallikrein 8 | Kallikrein-8 | NP | NRPN | Neuropsin | Ovasin | PRSS19 | Serine protease 19 | Serine protease TADG-14 | TADG14 | Tumor-associated differentially expressed gene 14 protein | hK8 |
Type: | PROTEIN |
Mol. Mass.: | 28053.09 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_600069 |
Residue: | 260 |
Sequence: | MGRPRPRAAKTWMFLLLLGGAWAGHSRAQEDKVLGGHECQPHSQPWQAALFQGQQLLCGG
VLVGGNWVLTAAHCKKPKYTVRLGDHSLQNKDGPEQEIPVVQSIPHPCYNSSDVEDHNHD
LMLLQLRDQASLGSKVKPISLADHCTQPGQKCTVSGWGTVTSPRENFPDTLNCAEVKIFP
QKKCEDAYPGQITDGMVCAGSSKGADTCQGDSGGPLVCDGALQGITSWGSDPCGRSDKPG
VYTNICRYLDWIKKIIGSKG
|
|
|
BDBM50525901 |
---|
n/a |
---|
Name | BDBM50525901 |
Synonyms: | CHEMBL4448315 |
Type | Small organic molecule |
Emp. Form. | C21H20BClFN3O3 |
Mol. Mass. | 427.664 |
SMILES | Cl.NC(=N)c1ccc(CC2OB(O)c3ccc(F)cc23)cc1OCc1cccnc1 |
Structure |
|